pharmatech bpc 157 BPC-157 – Alphaceuticals by Dr. Catherine BPC-157: Experimental Peptide Creates Risk

Pancreatic Enzymes: In rare cases where the pancreas is severely damaged and can no longer produce enough digestive enzymes (a condition called Exocrine Pancreatic Insufficiency or EPI), enzyme supplements must be added to every meal

Japan Intractable Diseases Information Center, Amyotrophic lateral sclerosis (ALS), Designated intractable disease (2)

Consumers may also wish to review the FDA's general guidance on dietary supplement labeling and claims, as well as current regulatory developments related to peptide compounds

The efficacy of DEFA1 is higher than that of the antimicrobial peptide magainin II and the conventional antibiotics ampicillin, clarithromycin or rifampicin, typically used for treatment of Rh